Xeris Biopharma Holdings, Inc. — 10-Q Filings
13 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Xeris Biopharma Holdings, Inc. (XERS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Xeris Biopharma Holdings, Inc. has filed 13 10-Q documents with the SEC since 2021. To view all SEC filings by Xeris Biopharma Holdings, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B5
425
8-K
8-K12B
ARS
CORRESP
DEF 14A
DEFA14A
EFFECT
S-3
S-4
S-4/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001867096-25-000159 | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001867096-25-000136 | Aug 7, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001867096-25-000089 | May 8, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001867096-24-000187 | Nov 8, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001867096-24-000162 | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001867096-24-000065 | May 9, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0001867096-23-000139 | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001867096-23-000114 | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001867096-23-000069 | May 9, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001867096-22-000127 | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001867096-22-000107 | Aug 10, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001867096-22-000063 | May 11, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001867096-21-000069 | Nov 10, 2021 | Sep 30, 2021 |